Skip to content
Disclosery

Cane Capital Partners, LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cane Capital Partners, LLC on GSK, newest first. How the timeline and the estimate are built.

Cane Capital Partners, LLC held 9,120 GSK shares at 2026-06-30 per its 13F-HR filed 2026-08-05.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 9,120 shares
    Change vs previous 13F +1,330 shares

    0.19% of the 13F portfolio, value $478,070.

    13F-HR 0002086121-26-000009 filed by Cane Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,790 shares
    Change vs previous 13F -600 shares

    0.19% of the 13F portfolio, value $429,930.

    13F-HR 0002086121-26-000007 filed by Cane Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 8,390 shares
    Change vs previous 13F not available

    0.17% of the 13F portfolio, value $411,446.

    13F-HR 0002086121-26-000002 filed by Cane Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).